PharmaDeals Review
PharmaDeals® Review is a monthly publication that analyses specific deals and examines trends and developments within deal making in different technology and therapy areas. It also assesses data from PharmaDeals Agreements and details product licensing openings from PharmaDeals Opportunities. Individual deals and selected companies’ collaborative histories are reviewed, providing useful insight into their deal making strategies. PharmaDeals Review offers a means of quickly reviewing competitive alliances, and assessing their impact on your business.
Download a sample issue of the PharmaDeals Review
Benefit from:
- Extensive articles - providing subscribers with extra deal analysis
- Deal Tracker - late-phase and recently launched products are explored from the perspective of the deals done to bring them through development, offering insight into the complex alliance history of individual drugs
- Analyst Opinion - experts provide in-depth analysis of recent deals, presenting commentary and opinion
- Business Commentary - Dr Fintan Walton, PharmaVentures’ CEO, comments on topical industry issues and how they may impact on deal making and the industry in general
PharmaDeals Review provides in-depth analysis of the key developments within deal making. By subscribing to PharmaDeals Review over a period of time, you will have the facility to track these deal trends at a glance.
